Abbott Laboratories (NYSE:ABT) is among the Best Brain-Computer Interface Stocks. On June 4, Reuters reported a federal judge ...

Backed by bullish positioning from 73 hedge funds and analyst expectations of 30.93% upside, Abbott Laboratories (NYSE:ABT) ...

ABT's Medical Devices unit builds on strong growth with new diabetes, heart rhythm and electrophysiology advances ahead of Q2 ...

In the latest close session, Abbott (ABT) was down 2.28% at $89.17. The stock trailed the S&P 500, which registered a daily loss of 1.62%. Meanwhile, the Dow lost 1.87%, and the Nasdaq, a tech-heavy ...

Some prosecutors believed they had enough to charge Abbott Laboratories, but senior officials opted for civil settlement.

Abbott Laboratories (NYSE:ABT) is a stock with characteristics suited to multi-decade ownership, because its four-segment ...

On June 17, Citi reiterated its Buy rating on Abbott Laboratories (NYSE:ABT). It said that the company’s individual businesses may be worth more than the market currently values the company as a whole ...

Abbott Labs could rally in a downturn and has a long-term growth catalyst to boot.

From transit to daily transactions, the rise of real-time, account-based payments is reshaping how Filipinos pay and travel.

Op-ed: Our new research shows that resident services, long considered a soft amenity, should be core infrastructure that ...

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) at $90.53 is a Buy. The healthcare giant has been swept up in a ...

DUBAI: Dubai’s Roads and Transport Authority (RTA) has announced the completion of 72% of the project to develop and upgrade the existing nol system, currently operating on card-based ticketing (CBT), ...